Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

Chao, Mark P., Jaiswal, Siddhartha, Weissman-Tsukamoto, Rachel, Alizadeh, Ash A., Gentles, Andrew J., Volkmer, Jens, Weiskopf, Kipp, Willingham, Stephen B. +4 more·2010·Science Translational Medicine

DOI 10.1126/scitranslmed.3001375

Cited by (779)

Items 501–600 of 779

CD (Cluster of Differentiation)
Sukhbir Kaur, Jeffrey S Isenberg, David D Roberts · 2011 · Springer eBooks
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously
Wen Luo, Hai Hoang, Katherine E. Miller, Hongwen Zhu, Serena Xu, Xiaokui Molly Mo, Elizabeth A.R. Garfinkle, Heather M. Costello, Saranga Wijeratne, Wiebke Chemnitz et al. · 2024 · Journal of Experimental & Clinical Cancer Research
Role of CD47 gene expression in colorectal cancer: a comprehensive molecular profiling study
Hiroyuki Arai, Nishant S. Gandhi, Francesca Battaglin, Jingyuan Wang, Sandra D. Algaze, Priya Jayachandran, Shivani Soni, Wu Zhang, Yan Yang, Joshua Millstein et al. · 2024 · Journal for ImmunoTherapy of Cancer
Metal-organic framework-based radiosensitizer for cancer therapy
Yingling Xie, Yu Xu, Yi Liu, Zijie Mei, Jian Tian · 2025 · Coordination Chemistry Reviews
Oncolyic Virotherapy for Prostate Cancer: Lighting a Fire in Winter
Gongwei Wang, Ying Liu, Shuoru Liu, Yuan Lin, Cheng Ping Hu · 2022 · International Journal of Molecular Sciences
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis
Alfonso Serrano del Valle, Manuel Beltrán‐Visiedo, Victoria de Poo-Rodríguez, Nelia Jiménez‐Alduán, Gemma Azaceta, Rosana Díez, Beatriz Martínez-Lázaro, Isabel Izquierdo, Luis Palomera, Javier Naval et al. · 2022 · OncoImmunology
Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation
Ruochen Du, Shashwat Tripathi, Hinda Najem, Daniel Jay Brat, Rimas Vincas Lukas, Peng Zhang, Amy B. Heimberger · 2024 · Cells
Cell Death and Cancer, Novel Therapeutic Strategies
Silvina Grasso, María Piedad Fernández-Pérez, Estefana Carrasco-Garca, Leticia Mayor-López, Elena Tristante, Lourdes Rocamora‐Reverte, ngeles Gmez-Martnez, Pilar García-Morales, Jos A., Miguel Saceda et al. · 2012 · InTech eBooks
Two novel calreticulin-related molecules with microbial binding and phagocytosis enhancing capacity in the half-smooth tongue sole, Cynoglossus semilaevis
Guanghua Wang, Zengjie Jiang, Shuwen He, Min Zhang · 2017 · Fish & Shellfish Immunology
缺氧诱导因子（HIF）与肝癌发展预后的综述
川北医学院第二临床医学院, 国栋梁 · 2022 · 肿瘤研究与治疗
Exosomal miRNAs as Next-generation Therapy Vehicles in Breast Cancer
Priyanka Thakur, Harshita Dahiya, Ankur Kaushal, Vijai Kumar Gupta, Adesh Kumar Saini, Reena Vohra Saini · 2023 · Current Gene Therapy
Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment
Zhengping Che, Wei Wang, Lin Zhang, Zhenghong Lin · 2024 · Journal of Pharmaceutical Analysis
Neutrophil extracellular traps–STC1 positive feedback loop promotes immune evasion and metastasis in bladder cancer
Tingting Cai, Tao Feng, Wei Zhang, Qintao Ge, Liangju Peng, Yue Wang, Jindong Xie, Xinpei Deng, Wenkai Zhu, Shengming Jin et al. · 2025 · Journal for ImmunoTherapy of Cancer
Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting
Qianlu Yang, Jie Yan, Qianxi Yang · 2026 · Clinical and Translational Medicine
Calreticulin—From the Endoplasmic Reticulum to the Plasma Membrane—Adventures of a Wandering Protein
Gillian C. Okura, Alamelu G. Bharadwaj, David M. Waisman · 2025 · Cancers
Evolution of normal and neoplastic tissue stem cells: progress after Robert Hooke
Irving L. Weissman · 2015 · Philosophical Transactions of the Royal Society B Biological Sciences
Trypanosoma cruzi calreticulin: In vitro modulation of key immunogenic markers of both canine tumors and relevant immune competent cells
Pablo Cruz, Eduardo Sosoniuk-Roche, I. Maldonado, Cristian Gabriel Torres, A. Ferreira · 2019 · Immunobiology
Type-I Interferon Signaling Is Essential for Robust Metronomic Chemo-Immunogenic Tumor Regression in Murine Breast Cancer
Cameron Vergato, Kshama A. Doshi, Darren M. Roblyer, David J. Waxman · 2022 · Cancer Research Communications
Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients
Marianne Agerlund Petersen, Carina Agerbo Rosenberg, Marie Bill, Marie Beck Enemark, Ole Rahbek, Anne Stidsholt Roug, Henrik Hasle, Bent Honoré, Maja Ludvigsen · 2022 · Cancers
Stem Cells, Cell Differentiation, and Cancer
Piero D. Dalerba, Maximilian Diehn, Irving L. Weissman, Michael F. Clarke · 2020 · Elsevier eBooks
Advances in nanoplatform-based multimodal combination therapy activating STING pathway for enhanced anti-tumor immunotherapy
Huizhong Zhang, Xiaohan Xu, Shiman Li, Huating Huang, Ke Zhang, Wenjing Li, Xinzhu Wang, Jingwen Yang, Xingbin Yin, Changhai Qu et al. · 2025 · Colloids and Surfaces B Biointerfaces
Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin‐mediated Phagocytic Effects for Lung Cancer Treatment
Zihan Ye, Wei‐Bang Yu, Mu‐Yang Huang, Yan‐Yan Chen, Lele Zhang, Chung‐Hang Leung, Xiaolei Zhang, Zheng-Hai Tang, Ting Li, Jin‐Jian Lu · 2025 · Advanced Science
Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins
Kexin Li, Qingji Huo, Nathan H. Dimmitt, Guofan Qu, Junjie Bao, Pankita H. Pandya, Mohammad Reza Saadatzadeh, Khadijeh Bijangi‐Vishehsaraei, Melissa A. Kacena, Karen E. Pollok et al. · 2023 · eLife
Chromosomal instability induced in cancer can enhance macrophage-initiated immune responses that include anti-tumor IgG
Brandon H. Hayes, Mai Wang, Hui Zhu, Steven H. Phan, Lawrence J. Dooling, Jason C. Andrechak, Alexander H Chang, Michael P. Tobin, Nicholas M. Ontko, Tristan Marchena et al. · 2023 · eLife
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond
Salvatore Perrone, Paolo Lopedote, Vitaliana De Sanctis, I. Iamundo De Cumis, Alessandro Pulsoni, Paolo Strati · 2023 · Cancers
From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia
Lauren A. Thurgood, Tim Chataway, Karen M. Lower, Bryone Jean Kuss · 2017 · Journal of Proteomics
Treatment of Saos‑2 osteosarcoma cells with diallyl trisulfide is associated with an increase in calreticulin expression
Wen‐Peng Xie, Yue Zhang, Yong‐Kui Zhang, Gang Li, Jian Xin, Rongxiu Bi, Chuan‐Jie Li · 2018 · Experimental and Therapeutic Medicine
Nature Biotechnology's academic spinouts of 2016
Aaron J. Bouchie, Laura DeFrancesco, Cormac Sheridan, Sarah Webb · 2017 · Nature Biotechnology
Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity
Michael C. Brown · 2022 · Cancer treatment and research
Radio-chemotherapy of glioblastoma cells promotes phagocytosis by macrophages in vitro
Marc Lecoultre, Sylvie Chliate, Felipe I. Espinoza, Stoyan Tankov, Valérie Dutoit, Paul R. Walker · 2023 · Radiotherapy and Oncology
Immune regulation effect of lienal polypeptides extract in Lewis lung carcinoma-bearing mice treated with cyclophosphamide
Yanping Wu, Jie Deng, Shu‐Hua Ouyang, Zhong‐Fu Mao, Guo-En Wang, Hiroshi Kurihara, Rong‐Rong He, Yi-Fang Li · 2017 · Experimental Biology and Medicine
Anticancer Properties of Curcumin and Interactions With the Circadian Timing System
Arpan De, Dilshan Harshajith Beligala, Tyler M. Birkholz, Michael Eric Geusz · 2019 · Integrative Cancer Therapies
Three unconventional maxims in the natural selection of cancer cells: Generation of induced tumor-suppressing cells (iTSCs)
Kexin Li, Qingji Huo, Bai‐Yan Li, Hiroki Yokota · 2023 · International Journal of Biological Sciences
Targeting Frequent Efferocytosis in Tumor Microenvironment is a New Direction for Cancer Treatment
Gangxing Zhu, Xinliang Wan, Wanyin Wu, Luyu Jia, Xiaoyan Yu, Handan Mo, Xi Wang, Qichun Zhou, Qing Tang, Sumei Wang · 2025 · Small Science
Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
Wenqi Zhang, Yanfeng Fan, Meng Li, Linqi Yang, Zhenya Zhang, Lihong Liu · 2021 · Disease Markers · Retracted
Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer
Ke Zhu, Wen Deng, Hui Deng, Xiaoqiang Liu, Gongxian Wang, Bin Fu · 2021 · PPAR Research
The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy
Michal Votava, Robin Bartolini, Linda Čapková, Jitka Smetanová, Vachtenheim Jiri, Martin Kuchar, David Kalfeřt, Jan Plzák, Jiřina Bartůňková, Zuzana Ozaniak Strizova · 2022 · BMC Cancer
In vitro flow cytometry assay to assess primary human and mouse macrophage phagocytosis of live cells
Samantha Y. Liu, Naomi Mulugeta, Stephanie K. Dougan, Qiang Li · 2023 · STAR Protocols
Calreticulin: a quintessential multifaceted protein with therapeutic potential
Savita Bansal, Meenakshi Vachher, Archana Burman · 2023 · Journal of Proteins and Proteomics
Cytosolic Calreticulin Inhibits Microwave Radiation‐Induced Microvascular Endothelial Cell Injury Through the Integrin‐Focal Adhesion Kinase Pathway
Feifei Xu, Tianqi Tao, Xiao‐Reng Wang, Yuzhen Li, Dandan Song, Mi Liu, Xiu‐Hua Liu · 2014 · Microcirculation
Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune Surveillance
Yasuhiro Fujiwara, Ryouichi Tsunedomi, Kiyoshi Yoshimura, Satoshi Matsukuma, Nobuyuki Fujiwara, Mitsuo Nishiyama, Shinsuke Kanekiyo, Hiroto Matsui, Yoshitaro Shindo, Yukio Tokumitsu et al. · 2021 · Pancreas
An Update on Immune Based Therapies in Acute Myeloid Leukemia: 2021 and Beyond!
Fadi Haddad, Naval Guastad Daver · 2021 · Advances in experimental medicine and biology
Ivermectin Enhanced Antitumor Activity of Resiquimod in a Co-Loaded Squalene Emulsion
Zhongkun Zhang, Jimmy Chun‐Tien Kuo, Chi Zhang, Yirui Huang, Robert J. Lee · 2022 · Journal of Pharmaceutical Sciences
Calreticulin nuclear translocalization alleviates CaM/CaMKII/CREB signaling pathway to enhance chemosensitivity in HDAC inhibitor-resistant hepatocellular carcinoma cells
Yi‐Sheng Liu, Yu-Chun Chang, Wei‐Wen Kuo, Ming‐Cheng Chen, Tso‐Fu Wang, Tung‐Sheng Chen, Yueh‐Min Lin, Chi‐Cheng Li, Po‐Hsiang Liao, Chih‐Yang Huang · 2022 · Aging
Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy
Yanhua Yue, Yang Cao, Fei Wang, Naidong Zhang, Ziwei Qi, Xunyuan Mao, Shuxin Guo, Feng Li, Yanting Guo, Yan Lin et al. · 2022 · Leukemia Research
Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer
Qianqian Wang, Chunxaing Feng, Yuchun Chen, Tianming Peng, Yong Zhong Li, Kunlin Wu, Xiao‐Yong Pu, Hanzhong Chen, Jiumin Liu · 2023 · Journal of Immunology Research
Natural Killer (NK)- and T-Cell Engaging Antibody-Derived Therapeutics
Christoph Stein, Ingo A. Schubert, Georg H. Fey · 2012 · Antibodies
Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy
Daniel Sánchez, P Gregor, Karol Čurila, Iva Hoffmanová, Věra Hábová, Ludmila Tučková, Helena Tlaskalová‐Hogenová · 2016 · Autoimmunity
Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity
Nashwa Ismail Hashaad, Rasha Mohamed Fawzy, Abeer A. Aboelazm, Mohamed Ibrahim Youssef · 2017 · European Journal of Rheumatology
Anti-CD47 antibody eliminates bone tumors in rats
Shiqiang Fang, Hainan Yin, Zhen Song, Ruixin Li, Xuesheng Xie, Zengquan Gu · 2019 · Saudi Journal of Biological Sciences
Bio-nanoparticle based therapeutic vaccine induces immunogenic response against triple negative breast cancer.
Xuewei Bai, Yanmei Zhou, Qiushi Lin, Chiung‐Kuei Huang, Songhua Zhang, Rolf I. Carlson, Hossein Ghanbari, Bei Sun, Jack R. Wands, Xiaoqun Dong · 2021 · PubMed Central
Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations
Alberto Carturan, Sonia Morè, Antonella Poloni, Serena Rupoli, Erika Morsia · 2024 · Cancers
Age-associated immune dysregulation and B cell dysfunction drive severe outcomes in SFTSV infection
Eun-Ha Kim, Ho Bin Jang, Se‐Mi Kim, Dongbin Park, Young‐Il Kim, Seung‐Gyu Jang, Suhee Hwang, Woohyun Kwon, Isaac Choi, Jaemoo Kim et al. · 2025 · PLoS Pathogens
Overcoming resistance to immune checkpoint inhibitor therapy in acute myeloid leukemia
Vaibhav Agrawal, Amandeep Salhotra · 2026 · Frontiers in Oncology
Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects
Yuanyuan Yang, Weijie Zhang, Peixiang Lan · 2022 · Cancers
Calreticulin, a potential coregulator of immune checkpoints and biomarker associated with tumor microenvironment and clinical prognostic significance in breast invasive carcinoma
Jiali Lin, Yiwei Chen, Zexin Zhang, Qi Feng, Mingdi Zhang · 2024 · Environmental Toxicology
Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma
Shuai Han, Qinghe Wang, Mingquan Shen, Xingpeng Zhang, Jian Wang · 2024 · Heliyon
FVIIa-PAR2 signaling facilitates immune escape by reducing phagocytic potential of macrophages in breast cancer
Arnab Ghosh, Avinandan Bhoumick, Subhojit Paul, Akash Chatterjee, Subhasis Mandal, Abhimanyu Basu, Soma Mukhopadhyay, Kaushik Das, Prosenjit Sen · 2024 · Journal of Thrombosis and Haemostasis
NIR-activated endoplasmic reticulum stress amplifier to regulate phagocytosis for macrophage-mediated cancer immunotherapy
Yaru Zhang, Wenyu Xie, Jiamin Luo, Rui Zhen Gao, Zhimin Gao, Xinyi Wang, Yongxin Huang, Lin Chen, Meiling Tan, Zhiyao Hou · 2025 · Chemical Engineering Journal
Autologous tumoral esterase-driven therapeutic polymers sequentially orchestrated antigen-induction, STING activation and anti-angiogenesis for systemic cancer immune therapy
Nasha Qiu, Chang Xu, Zhen Zhang, Rui Wang, Xuyong Wei, Yangla Xie, Shuai Wang, Di Lu, Kai Wang, Shengjun Xu et al. · 2025 · Biomaterials
The (miR)e of CTCL
Anjali Mishra, Ramiro Garzon · 2014 · Blood
Changes in the in vitro activity of platinum drugs when administered in two aliquots
Zaynab Al-Eisawi, Philip James Beale, Charles Chan, Jun Yu, Nicholas W. Proschogo, Mark P. Molloy, Fazlul Huq · 2016 · BMC Cancer
Harnessing Genomic Stress for Antitumor Immunity
Congying Pu, Siyao Tao, Jun Xu, Min Huang · 2020 · Antioxidants and Redox Signaling
Myeloid Cell Origins, Differentiation, and Clinical Implications
Kipp Weiskopf, Peter John Schnorr, Wendy W. Pang, Mark Ping Chao, Akanksha Chhabra, Jun Seita, Mingye Feng, Irving L. Weissman · 2017 · ASM Press eBooks
Characterization of colorectal cancer by hierarchical clustering analyses of five immune cell markers
Sunao Ito, Akira Koshino, Masayuki Komura, Shunsuke Kato, Takahiro Otani, Chengbo Wang, Akane Ueki, Hiroki Takahashi, Masahide Ebi, Naotaka Ogasawara et al. · 2023 · Pathology International
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models
Yasuyuki Saito, Rie Iida‐Norita, Tania Afroj, Alaa Refaat, Daisuke Hazama, Satomi Komori, Shinya Ohata, Tomoko Takai, Okechi S. Oduori, Takenori Kotani et al. · 2023 · Frontiers in Immunology
Enhanced treatment of breast cancer brain metastases with oncolytic virus expressing anti-CD47 antibody and temozolomide
Jing Wang, Lei Tian, Tasha Barr, Lewei Jin, Yuqing Chen, Zhiyao Li, Ge Wang, Jian-Chang Liu, Li‐Shu Wang, Jianying Zhang et al. · 2024 · Molecular Therapy Oncology
Calreticulin mRNA expression and clinicopathological characteristics in acute myeloid leukemia
Sholhui Park, Hee Jin Huh, Yeung‐Chul Mun, Chu‐Myong Seong, Wha Soon Chung, Hae‐Sun Chung, Jungwon Huh · 2015 · Cancer Genetics
Shc Is Implicated in Calreticulin-Mediated Sterile Inflammation in Alcoholic Hepatitis
Yuan Li, Joy X. Jiang, Weiguo Fan, Sarah R. Fish, Suvarthi Das, Parul Gupta, Gergely D. Mozes, Lóránd Váncza, Sutapa Sarkar, Koshi Kunimoto et al. · 2022 · Cellular and Molecular Gastroenterology and Hepatology
Potential Application of Small Interfering RNA in Gastro-Intestinal Tumors
Pasquale Losurdo, Nicolò de Manzini, Silvia Palmisano, Mario Grassi, Salvatore Parisi, Flavio Rizzolio, Domenico Tierno, Alice Biasin, Chiara Grassi, Nhung Hai Truong et al. · 2022 · Pharmaceuticals
CD47/SIRPα pathways: Functional diversity and molecular mechanisms
Nitin Bhardwaj, Harish Mani Chandra, Ashutosh Singh, Ram Babu · 2025 · World Journal of Biological Chemistry
Dendritic cells-derived extracellular vesicles in tumourigenesis: From biological roles to clinical implications
Qingning Chen, Weiyuan Wang, Xiaoyun He, Chunrong Wang, Hongbin Guo, Chunlin Ou · 2025 · Cancer Letters
Expression and Clinical Significance of CD47 in Colorectal Cancer: A Review
Qijie Li, Paola Vignali, Donghao Tang, Giulia Martinelli, Beatrice Fuochi, Rebecca Sparavelli, Anello Marcello Poma, Rossella Bruno, Elisabetta Macerola, Clara Ugolini · 2025 · Cancers
Harnessing autologous immune effector mechanisms in acute myeloid leukemia: 2023 update of trials and tribulations
Shyam Ajay Patel, Elisa Bello, Andrew Wilks, Jonathan Michael Gerber, Narayanan Sadagopan, Jan Černý · 2023 · Leukemia Research
High Expression of Calreticulin Affected the Tumor Microenvironment and Correlated With Worse Prognosis in Patients With Triple-Negative Breast Cancer
Xi Cao, Xinyu Ren, Yu Min Song, Qiang Sun, Feng Mao, Songjie Shen, Chang Chen, Yidong Zhou · 2025 · Journal of Immunotherapy
Lymphoma spread? Target CD47-SIRPα!
Marcel Spaargaren · 2011 · Blood
Identification of promising prognostic genes for relapsed acute lymphoblastic leukemia
Chai Ji, Sheng‐Liang Lin, Dan Yao, Mingyan Li, Weijun Chen, Shuangshuang Zheng, Zhengyan Zhao · 2019 · Blood Cells Molecules and Diseases
Proteome derangement in malignant epithelial cells and its stroma following exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
Kent L. Marshall, Yaw Twum, Weimin Gao · 2022 · Archives of Toxicology
Immunotherapy with Monoclonal Antibodies for Acute Myeloid Leukemia: A Work in Progress
Matteo Molica, Salvatore Perrone, Costanza Andriola, Marco Rossi · 2023 · Cancers
Therapeutic Antibodies and Immunologic Conjugates
Nai‐Kong V. Cheung · 2014 · Elsevier eBooks
Immunogenic Stress and Death of Cancer Cells in Natural and Therapy-Induced Immunosurveillance
Oliver Kepp, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer · 2017 · Springer eBooks
CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
Alexandre Nonino, Juliana Minuncio Nascimento, Cintia C. Mascarenhas, Juliana Forte Mazzeu, R.W. Pereira, Rafael Henriques Jácomo · 2018 · Brazilian Journal of Medical and Biological Research
Genetic Screening for Novel Regulators of Immune Checkpoint Molecules
Ramon Arens, Ferenc A. Scheeren · 2020 · Trends in Immunology
Emerging immuno-oncology targets in Myelodysplastic Syndromes (MDS)
Michael Mann, Andrew Mark Brunner · 2021 · Current Problems in Cancer
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia
Andrew Mark Brunner · 2022 · Current Opinion in Hematology
Marine natural product lepadin A as a novel inducer of immunogenic cell death via CD91-dependent pathway
Dalila Carbone, Carmela Gallo, Genoveffa Nuzzo, Giusi Barra, Mario dell’Isola, Mario Affuso, Olimpia Follero, Federica Albiani, Clementina Sansone, Emiliano Manzo et al. · 2023 · Natural Products and Bioprospecting
Does cancer cell-expressed SLAMF7 impact on CD47-mediated phagocytosis?
Renée Bouwstra, Tom van Meerten, Edwin Bremer · 2019 · Molecular & Cellular Oncology
Biomineralized Zn2+-siRNA complex enhances CD47 blockade therapy by facilitating phagocytosis and mtDNA sensing
Zhiwen Zou, Jiaxin Li, Hongyu Liu, Bingwen Ding, Xiaoyu Huang, Zhu Zhu, Li Liang, Miaorong Yu, Jinhui Wu, Yong Gan · 2025 · Cell Biomaterials
Next-Generation Immune Checkpoint Inhibitors in Cancer: Mechanisms, Current Clinical Advances, and Future Directions
Tabish Hussain, Dhurjhoti Saha, Abhijit Chakraborty · 2025 · Journal of Cancer Immunology
Calreticulin surface presentation: a signal for natural killer cells to attack
Jasmine P Castellanos, Joseph C. Genereux · 2023 · Signal Transduction and Targeted Therapy
Identification and characterization of calreticulin as a novel plasminogen receptor
Alamelu G. Bharadwaj, Gillian C. Okura, John W. Woods, Erica A. Allen, Victoria Ann Miller, Emma Kempster, Mark A. Hancock, Shashi Ashok Gujar, Rimantas Slibinskas, David M. Waisman · 2023 · Journal of Biological Chemistry
Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47
Matthew R. Levengood, Christopher M. Carosino, Xinqun Zhang, Sasha Y. Lucas, David J. Ortiz, Lori Westendorf, Alice P. Chin, Arlan D. Martin, Abbie Wong, Shawna Mae Hengel et al. · 2024 · Molecular Cancer Therapeutics
Phosphoproteomic Profiling Reveals mTOR Signaling in Sustaining Macrophage Phagocytosis of Cancer Cells
Bixin Wang, Xu Cao, Krystine Garcia‐Mansfield, Jingkai Zhou, Antigoni Manousopoulou, Patrick Pirrotte, Yingyu Wang, Leo David Wang, Mingye Feng · 2024 · Cancers
Oncolytic viruses targeting CD47: a new road to success?
Chris H.M. Takimoto, Michael J. Wick · 2025 · Journal for ImmunoTherapy of Cancer
Using tunable hydrogel microparticles to measure cellular forces
Alvja Mali, Youri Peeters, Rick Rodrigues de Mercado, Alexander H. Settle, Matthew J. Footer, Mangala Srinivas, Julie A. Theriot, Daan Vorselen · 2025 · Nature Protocols
Immunogenic cell death as a cornerstone for combination therapies with immune checkpoint blockade
Yubo Niu, Shuangli Zhu, Kai Fu, Y Y Lai, Can Pan, Yanrong Yang, Sijia Li, Xueping Wang, K F To, Fang Wang et al. · 2026 · Molecular Cancer
Biology of tumour growth
Derek C. Knottenbelt, Janet C. Patterson‐Kane, Katie L. Snalune · 2015 · Elsevier eBooks
Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma
Ming Sun, Shanshan Qi, Min Wu, Wei Xia, Hao Xiong · 2022 · Frontiers in Genetics
Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma
Lizhu Chen, Jiexiang Lin, Yaoming Wen, Yu Chen, Chuanben Chen · 2023 · Frontiers in Oncology
IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity
Anahita Rafiei, Marco Gualandi, Chia-Lung Yang, Richard Woods, Anil Kumar, Kathrin Brunner, John Sigrist, Hilmar Ebersbach, Steve Coats, Christoph Renner et al. · 2024 · Cancers